NextSeq 1000 & NextSeq 2000 Innovation & Expertise
Innovations that empower researchers across the globe
Illumina is committed to upholding a proven track record of solutions that empower researchers to advance and accelerate their sequencing. That’s why we have invested billions into our research and development and infrastructure to ensure we can equip you with what you need to succeed.
When you partner with Illumina, you’ll get more than just leading-edge technology–you become part of a community with like-minded goals.
Inspiring bold discoveries with global expertise
Our pursuit of innovation continues to inspire scientists to join our growing genomics community, and our proven performance has contributed to Illumina being cited more than any other sequencing company.
369,000+
Sequencing publications
9,000+
Customers served
20,000+
Instruments installed
3,000+
Trainings per year
15+
Illumina Solution Centers
600+
Support personnel
150+
Countries served
>$1B
in R&D investment
Find community and get comprehensive support at every step
Illumina provides a wide range of global, in-language support including remote technical support 24/5, onsite training, instrument qualification and customized onboarding solutions. Because of this, 9 out of 10 customers find it easy to do business with our team.
Get comprehensive support
- 96% customer satisfaction
- 97% of calls answered in <30 seconds
- <1 day mean time to repair
- 2-day average FSE response time
Connect with fellow innovators
Become a part of a community advancing science together by leading the latest advancements in research and sharing best practices.
Explore Illumina collaborations
Illumina partnerships are expanding access to NGS, pioneering new applications and technologies, providing funding for innovative startups, and more.
Advance your research with streamlined, sustainable benchtop sequencing
Streamline your workflows
Lessen time-to-insight with simple workflows from library prep to data analysis.
Sequence sustainably
Reduce your environmental footprint with sustainable solutions.
Join thousands of researchers who have simplified their sequencing
NextSeq 1000 and NextSeq 2000 Sequencing Systems are flexible and scalable, empowering scientists to explore current and emerging applications like single cell, whole exome, and RNA sequencing. These easy-to-use systems feature an improved user experience with simplified run setup, minimal touchpoints, and flexible informatics solutions, including onboard DRAGEN. The breakthrough system design uses integrated reagent cartridges to minimize waste volume and improve recyclability.
See how Illumina benchtop sequencers can transform your lab—today
With the help of the NextSeq 2000, Jun Xia, PhD and Yusi Fu, PhD of Creighton University developed highly accurate single-cell sequencing methods to detect cancer biomarkers. Hear how the NextSeq 2000 fast-tracked their research, opening doors with collaborators to better understand the fundamental processes that drive cancer.
Make your most ambitious research a reality with NextSeq 1000 and NextSeq 2000 innovations
- <10 minute interface setup with local, cloud, or hybrid run setup
- Up to 11 different flow cell configurations, with more to come, supporting a wide range of applications
- Compatibility with a broad range of library prep solutions
- Dry instrument design and integrated single cartridge for streamlined maintenance, optimized instrument up-time, and minimal waste
Empowering even more discoveries: XLEAP-SBS chemistry coming H1 2024
Achieve the next level of scale, cost efficiencies, and sequencing capabilities on NextSeq 1000 and NextSeq 2000 Sequencing Systems. Coming in the first half of 2024, XLEAP-SBS Chemistry on existing kits (P1/P2/P3) and a new P4 flow cell will offer 1.7B reads and allow for 500Gb of genomic data.
"Using the NextSeq 2000 instrument has put our laboratory [into] a completely different league. The higher throughput and faster turnaround time made it possible for us to generate our results and reports much faster and [in] a more comprehensive way."
NextSeq 1000 and NextSeq 2000 are the only benchtop sequencers with integrated, onboard analysis—at no extra cost
With the NextSeq 1000 and NextSeq 2000 onboard DRAGEN software, labs can reduce the need for additional computing infrastructure and bioinformatics resources. And with decreased data analysis complexity, researchers can efficiently find key insights in large data sets.
3x reduction in touchpoints for analysis data with BaseSpace
6x faster on-board secondary analysis than Local Run Manager
10+ pipelines that support a wide variety of experiment types
80% less energy for a more sustainable workplace
Up to 5x decrease in data footprint possible with ORA Compression
Speak to a specialist about choosing
Illumina for your benchtop sequencer
Get in touch to find out how Illumina benchtop sequencing can support your research efforts.
Speak with salesHear from the scientific community
Managing throughput demands to support critical programs
In this video, learn about the robustness of the NextSeq 2000 System and how it was able to support Dr Tomas Szemes’ team from Comenius University Science Park, in Slovakia, to double their previous sequencing efforts.
Enriching sequencing workflows with NextSeq 1000 and NextSeq 2000 Systems
Hear from researchers who have used the NextSeq 1000 and NextSeq 2000 Systems for genomic surveillance, CRISPR screening, single-cell RNA Seq, and more, in this introductory video.
Expanding applications and utility with longer reads and extended informatics
Gain a deeper perspective on the flexibility, streamlined workflow, flow cell configurations, informatics, and future innovations of the NextSeq 1000 and NextSeq 2000 Systems in this webinar.
References
- Internal data on file. Illumina, Inc., 2022